// App-Quantinova.ai

694 : Evaluation of the Effect of UCB4470 (anti-mouse FcRn) on Amelioration of Thrombosis in a Mouse Model of Antiphospholipid (aPL)-induced Thrombosis

Researchers

Presenter

  • Maria Laura Bertolaccini

Principal Investigators

  • Yiannis Ioannou

  • Helen Neale

  • Prakash Saha

  • Alberto Smith

Medical Centers

  • Kings College London, London, United Kingdom

  • UCB Biopharma SRL, London, United Kingdom

  • UCB Pharma, Slough, UK Slough United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Lupus

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved